Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events: Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)"

Ido Weinberg; Joshua A. Beckman; Yu Shu; Michael R. Jaff

doi:10.1161/CIRCULATIONAHA.118.034734

Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events: Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)"

Ido Weinberg, Joshua A. Beckman, Yu Shu, Michael R. Jaff

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2676-2677
Number of pages	2
Journal	Circulation
Volume	137
Issue number	24
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.118.034734
State	Published - Jun 12 2018
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.118.034734

Cite this

Weinberg, I., Beckman, J. A., Shu, Y., & Jaff, M. R. (2018). Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events: Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)". Circulation, 137(24), 2676-2677. https://doi.org/10.1161/CIRCULATIONAHA.118.034734

Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events : Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)". / Weinberg, Ido; Beckman, Joshua A.; Shu, Yu et al.

In: Circulation, Vol. 137, No. 24, 12.06.2018, p. 2676-2677.

Research output: Contribution to journal › Letter › peer-review

Weinberg, I, Beckman, JA, Shu, Y & Jaff, MR 2018, 'Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events: Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)"', Circulation, vol. 137, no. 24, pp. 2676-2677. https://doi.org/10.1161/CIRCULATIONAHA.118.034734

Weinberg I, Beckman JA, Shu Y, Jaff MR. Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events: Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)". Circulation. 2018 Jun 12;137(24):2676-2677. doi: 10.1161/CIRCULATIONAHA.118.034734

Weinberg, Ido ; Beckman, Joshua A. ; Shu, Yu et al. / Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events : Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)". In: Circulation. 2018 ; Vol. 137, No. 24. pp. 2676-2677.

@article{24605abb1d1b45b1b316c502643077fe,

title = "Response by weinberg et al to letter regarding article, {"}carotid stent fractures are not associated with adverse events: Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease){"}",

author = "Ido Weinberg and Beckman, {Joshua A.} and Yu Shu and Jaff, {Michael R.}",

note = "Funding Information: Dr Beckman reports consulting for Astra Zeneca, Sanofi, Aralez, and Abbott; a research grant from Merck; ownership in EMX and Janacare; and nonprofit board membership for VIVA and SY. Dr Beckman also serves on the Data Safety Monitoring Board for Bayer. Dr Shu is an employee of Abbott Vascular. Dr Jaff is a noncompensated advisor for Abbott Vascular, Boston Scientific, Cordis, and Medtronic; is a consultant for Philips/Volcano; has equity investment in PQ Bypass, Primacea, Vascular Therapies, and Venarum; and is a board member for VIVA Physicians, a 501(c)(3) not-for-profit education and research organization. Dr Weinberg has no disclosures to report.",

year = "2018",

month = jun,

day = "12",

doi = "10.1161/CIRCULATIONAHA.118.034734",

language = "English (US)",

volume = "137",

pages = "2676--2677",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "24",

}

TY - JOUR

T1 - Response by weinberg et al to letter regarding article, "carotid stent fractures are not associated with adverse events

T2 - Results from the ACT-1 multicenter randomized trial (Carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with significant extracranial carotid stenotic disease)"

AU - Weinberg, Ido

AU - Beckman, Joshua A.

AU - Shu, Yu

AU - Jaff, Michael R.

N1 - Funding Information: Dr Beckman reports consulting for Astra Zeneca, Sanofi, Aralez, and Abbott; a research grant from Merck; ownership in EMX and Janacare; and nonprofit board membership for VIVA and SY. Dr Beckman also serves on the Data Safety Monitoring Board for Bayer. Dr Shu is an employee of Abbott Vascular. Dr Jaff is a noncompensated advisor for Abbott Vascular, Boston Scientific, Cordis, and Medtronic; is a consultant for Philips/Volcano; has equity investment in PQ Bypass, Primacea, Vascular Therapies, and Venarum; and is a board member for VIVA Physicians, a 501(c)(3) not-for-profit education and research organization. Dr Weinberg has no disclosures to report.

PY - 2018/6/12

Y1 - 2018/6/12

UR - http://www.scopus.com/inward/record.url?scp=85053876951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053876951&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.118.034734

DO - 10.1161/CIRCULATIONAHA.118.034734

M3 - Letter

C2 - 29891632

AN - SCOPUS:85053876951

SN - 0009-7322

VL - 137

SP - 2676

EP - 2677

JO - Circulation

JF - Circulation

IS - 24

ER -

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this